319 related articles for article (PubMed ID: 21400011)
1. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?
Piton G; Manzon C; Cypriani B; Carbonnel F; Capellier G
Intensive Care Med; 2011 Jun; 37(6):911-7. PubMed ID: 21400011
[TBL] [Abstract][Full Text] [Related]
2. Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality.
Piton G; Belon F; Cypriani B; Regnard J; Puyraveau M; Manzon C; Navellou JC; Capellier G
Crit Care Med; 2013 Sep; 41(9):2169-76. PubMed ID: 23782971
[TBL] [Abstract][Full Text] [Related]
3. Plasma citrulline kinetics and prognostic value in critically ill patients.
Piton G; Manzon C; Monnet E; Cypriani B; Barbot O; Navellou JC; Carbonnel F; Capellier G
Intensive Care Med; 2010 Apr; 36(4):702-6. PubMed ID: 20084502
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of gut barrier failure in the ICU.
Piton G; Capellier G
Curr Opin Crit Care; 2016 Apr; 22(2):152-60. PubMed ID: 26808138
[TBL] [Abstract][Full Text] [Related]
5. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.
Crenn P; Messing B; Cynober L
Clin Nutr; 2008 Jun; 27(3):328-39. PubMed ID: 18440672
[TBL] [Abstract][Full Text] [Related]
6. Assessment of small bowel function in critical illness: potential role of citrulline metabolism.
Peters JH; Beishuizen A; Keur MB; Dobrowolski L; Wierdsma NJ; van Bodegraven AA
J Intensive Care Med; 2011; 26(2):105-10. PubMed ID: 21464064
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine use is associated with enterocyte damage in critically ill patients.
Piton G; Cypriani B; Regnard J; Patry C; Puyraveau M; Capellier G
Shock; 2015 May; 43(5):437-42. PubMed ID: 25565647
[TBL] [Abstract][Full Text] [Related]
8. [Plasma citrulline concentration--a reliable noninvasive marker of functional enterocyte mass].
Oliverius M; Kudla M; Baláz P; Valsamis A
Cas Lek Cesk; 2010; 149(4):160-2. PubMed ID: 20518248
[TBL] [Abstract][Full Text] [Related]
9. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.
Jianfeng G; Weiming Z; Ning L; Fangnan L; Li T; Nan L; Jieshou L
J Surg Res; 2005 Aug; 127(2):177-82. PubMed ID: 15921697
[TBL] [Abstract][Full Text] [Related]
10. Plasma citrulline correlates with basolateral amino acid transporter LAT4 expression in human small intestine.
Maric S; Flüchter P; Guglielmetti LC; Staerkle RF; Sasse T; Restin T; Schneider C; Holland-Cunz SG; Crenn P; Vuille-Dit-Bille RN
Clin Nutr; 2021 Apr; 40(4):2244-2251. PubMed ID: 33077272
[TBL] [Abstract][Full Text] [Related]
11. Enterocyte Damage: A Piece in the Puzzle of Post-Cardiac Arrest Syndrome.
Piton G; Belin N; Barrot L; Belon F; Cypriani B; Navellou JC; Capellier G
Shock; 2015 Nov; 44(5):438-44. PubMed ID: 26196845
[TBL] [Abstract][Full Text] [Related]
12. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans.
Crenn P; Coudray-Lucas C; Thuillier F; Cynober L; Messing B
Gastroenterology; 2000 Dec; 119(6):1496-505. PubMed ID: 11113071
[TBL] [Abstract][Full Text] [Related]
13. Plasma citrulline concentration and plasma LPS detection among critically ill patients a prospective observational study.
Chaignat C; Lagrost L; Moretto K; de Barros JP; Winiszewski H; Grober J; Saas P; Piton G
J Crit Care; 2024 Feb; 79():154438. PubMed ID: 37797404
[TBL] [Abstract][Full Text] [Related]
14. The IN-PANCIA Study: Clinical Evaluation of Gastrointestinal Dysfunction and Failure, Multiple Organ Failure, and Levels of Citrulline in Critically Ill Patients.
Fagoni N; Piva S; Marino R; Chiarini G; Ferrari D; Grespi E; Bertuetti R; Barbieri S; Latronico N; Rasulo F
J Intensive Care Med; 2020 Mar; 35(3):279-283. PubMed ID: 29141526
[TBL] [Abstract][Full Text] [Related]
15. Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill.
Blaser A; Padar M; Tang J; Dutton J; Forbes A
Anaesthesiol Intensive Ther; 2019; 51(3):230-239. PubMed ID: 31418255
[TBL] [Abstract][Full Text] [Related]
16. Impact of the route of nutrition on gut mucosa in ventilated adults with shock: an ancillary of the NUTRIREA-2 trial.
Piton G; Le Gouge A; Brulé N; Cypriani B; Lacherade JC; Nseir S; Mira JP; Mercier E; Sirodot M; Rigaud JP; Malaquin S; Soum E; Djibre M; Gaudry S; Thévenin D; Reignier J
Intensive Care Med; 2019 Jul; 45(7):948-956. PubMed ID: 31143999
[TBL] [Abstract][Full Text] [Related]
17. Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure.
Picot D; Garin L; Trivin F; Kossovsky MP; Darmaun D; Thibault R
Clin Nutr; 2010 Apr; 29(2):235-42. PubMed ID: 19744750
[TBL] [Abstract][Full Text] [Related]
18. Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease.
Crenn P; Vahedi K; Lavergne-Slove A; Cynober L; Matuchansky C; Messing B
Gastroenterology; 2003 May; 124(5):1210-9. PubMed ID: 12730862
[TBL] [Abstract][Full Text] [Related]
19. [Plasma citrulline concentration as a biomarker of intestinal function in short bowel syndrome and in intestinal transplant].
Vecino López R; Andrés Moreno AM; Ramos Boluda E; Martinez-Ojinaga Nodal E; Hernanz Macías A; Prieto Bozano G; Lopez Santamaria M; Tovar Larrucea JA
An Pediatr (Barc); 2013 Oct; 79(4):218-23. PubMed ID: 23528708
[TBL] [Abstract][Full Text] [Related]
20. Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage.
Barzał JA; Szczylik C; Rzepecki P; Jaworska M; Anuszewska E
Acta Biochim Pol; 2014; 61(4):615-31. PubMed ID: 25473654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
